Show items per page
Elements: 7
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Tools in the Assessment of Sarcopenia Cooper, C.; Fielding, R.; Visser, M.; van Loon, L. J.; ... Kanis, J. A. 2013
add to browser selection
Treatment of osteoporosis in men Kaufman, J.-M.; Reginster, J.-Y.; Boonen, S.; Brandi, M.L.; ... Rizzoli, René 2013
add to browser selection
Frailty and sarcopenia: definitions and outcome parameters Cooper, C.; Dere, W.; Evans, W.; Kanis, J. A.; ... Reginster, J.-Y. L. 2012
add to browser selection
Implications for Fracture Healing of Current and New Osteoporosis Treatments: An ESCEO Consensus Paper Goldhahn, J.; Féron, J.-M.; Kanis, J.; Papapoulos, S.; ... Boonen, S. 2012
add to browser selection
Management of Glucocorticoid-Induced Osteoporosis Rizzoli, René; Adachi, J. D.; Cooper, C.; Dere, W.; ... Reginster, J. Y. 2012
add to browser selection
The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES) Bruyere, O.; Kanis, J. A.; Ibar-Abadie, M-E; Alsayed, N.; ... Reginster, J-Y 2010
add to browser selection
Recommendations for the registration of agents for prevention and treatment of glucocorticoid-induced osteoporosis: an update from the Group for the Respect of Ethics and Excellence in Science Compston, J.; Reid, D M.; Boisdron, J.; Brandi, M-L.; ... Reginster, J-Y. 2008